Steven Simoens

Research interests

Publications

• The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

  Clinical Pharmacology & Therapeutics · 2020 · https://doi.org/10.1002/cpt.1836

• Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

  Frontiers in Public Health · 2018 · https://doi.org/10.3389/fpubh.2018.00328

• Outrageous prices of orphan drugs: a call for collaboration

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31069-9

• Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group

  Value in Health · 2018 · https://doi.org/10.1016/j.jval.2018.03.004

• Outrageous prices of orphan drugs: a call for collaboration

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31069-9

• Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

  Frontiers in Pharmacology · 2017 · https://doi.org/10.3389/fphar.2017.00171

• Policies for biosimilar uptake in Europe: An overview

  PLoS ONE · 2017 · https://doi.org/10.1371/journal.pone.0190147

• Insights into European Drug Shortages: A Survey of Hospital Pharmacists

  PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0119322

• Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

  Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.02.031

• Economic burden of inadequate management of allergic diseases in the European Union: a GA 2 LEN review

  Allergy · 2014 · https://doi.org/10.1111/all.12470

• The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey

  Human Reproduction · 2013 · https://doi.org/10.1093/humrep/det284

• Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

  Orphanet Journal of Rare Diseases · 2012 · https://doi.org/10.1186/1750-1172-7-74

• The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres

  Human Reproduction · 2012 · https://doi.org/10.1093/humrep/des073

• Pricing and reimbursement of orphan drugs: the need for more transparency

  Orphanet Journal of Rare Diseases · 2011 · https://doi.org/10.1186/1750-1172-6-42

• Economic effects of clinical pharmacy interventions: A literature review

  American Journal of Health-System Pharmacy · 2008 · https://doi.org/10.2146/ajhp070506

• Body composition, volumetric and areal bone parameters in male-to-female transsexual persons

  Bone · 2008 · https://doi.org/10.1016/j.bone.2008.09.001

• Endometriosis: cost estimates and methodological perspective

  Human Reproduction Update · 2007 · https://doi.org/10.1093/humupd/dmm010

• Sustaining Generic Medicines Markets in Europe

  Journal of Generic Medicines The Business Journal for the Generic Medicines Sector · 2006 · https://doi.org/10.1057/palgrave.jgm.4940128

• The Supply of Physician Services in OECD Countries

  OECD health working papers · 2006 · https://doi.org/10.1787/608402211700

• Tackling Nurse Shortages in OECD Countries

  OECD health working papers · 2005 · https://doi.org/10.1787/172102620474

• Impact, regulation and health policy implications of physician migration in OECD countries

  Human Resources for Health · 2004 · https://doi.org/10.1186/1478-4491-2-12

Current projects

No projects listed.